Located in the heart of Auckland’s CBD, optometrist trio Dr Vivienne Zhang, Charisse Kuo and Gina Partridge have opened New Zealand’s first clinic specialising in myopia management: the Auckland Myopia Clinic.
Aspen Pharmacare’s Eikance 0.01% atropine drops have been approved by Medsafe and will be available via prescription from pharmacies in New Zealand from the end of June 2024.
A US study found an artificial intelligence (AI) system matched, or in some cases outperformed, experienced ophthalmologists in their diagnoses and proposed treatments for glaucoma and retinal disease
Early data from the phase 2 trial of gene therapy Ixo-vec (ixoberogene soroparvovec, formerly ADVM-022), demonstrated potential best-in-class clinical activity in treatment burden reduction for “hard
Harmful gut bacteria found in the retinas of mice with certain inherited retinal diseases (IRDs) were treated with antimicrobials, preventing vision loss, reported the authors of a UK-Chinese study.
A large US study has shown recombinant zoster vaccine (RZV, Shingrix) exposure was associated with a 64% higher risk of herpes zoster ophthalmicus (HZO) recurrence in patients with prior HZO infection
The University of Western Australia has awarded a doctor of philosophy to Counties Manukau ophthalmologist Dr Anmar Abdul-Rahman for his “invaluable contribution to medical science”, including developing an artificial intelligence (AI) model to non-invasively predict intracranial pressure (ICP).
Apple’s recently granted patent describes smartglasses which could determine the wearer’s prescription and accommodation and adjust the lens’ optical power accordingly.
Hydroquinine, a naturally occurring compound used to treat malaria and muscle cramps, kills bacteria associated with microbial keratitis, reported a new study.
The Australian manufacturer of the repeated low-level red-light (RLRL) Eyerising Myopia Management Device has strongly rebutted claims made by University of Houston researchers cautioning that low-level red-light (LLRL) therapy can put the retina at risk of photochemical and thermal damage and is pr
The Optometrist and Dispensing Opticians Board (ODOB) is the authority responsible for regulating the optometrists and dispensing opticians in Aotearoa New Zealand. The board noted the article ‘Salaries – when aspiration should be reality’, published in NZ Optics’ October 2023 edition¹ which advocat
Promising to challenge current thinking and spark discussion, two of CCLS 2024’s keynote speakers, took time out of their busy schedules to talk about their research, interests and forthcoming trip to Aotearoa.
